MET and hepatocellular carcinoma: CuB substantially decreased the expression levels of activated AKT and phosphorylated mTOR, including p-AKTThr308, p-mTOR, and p-RPS6, in the liver lesions of AKT/c-Met-induced HCC mice, but total AKT levels remained unchanged.